ShareHope Medicine Co Ltd (8403) — Cash Flow-to-Debt Ratio
ShareHope Medicine Co Ltd (8403) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of NT$113.37 Million could theoretically repay 0% of its total liabilities (NT$2.78 Billion) in one year. See ShareHope Medicine Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ShareHope Medicine Co Ltd Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for ShareHope Medicine Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does ShareHope Medicine Co Ltd generate cash.
Annual Cash Flow-to-Debt Ratio for ShareHope Medicine Co Ltd (2017–2025)
Year-by-year debt coverage analysis for ShareHope Medicine Co Ltd. Check how high is ShareHope Medicine Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | NT$364.12 Million | NT$2.78 Billion | ▲ +53.1% |
| 2024 | 0.09x | NT$266.68 Million | NT$3.12 Billion | ▲ +16.0% |
| 2023 | 0.07x | NT$257.13 Million | NT$3.49 Billion | ▼ -62.4% |
| 2022 | 0.20x | NT$642.47 Million | NT$3.28 Billion | ▲ +21.3% |
| 2021 | 0.16x | NT$360.10 Million | NT$2.23 Billion | ▼ -52.6% |
| 2020 | 0.34x | NT$717.74 Million | NT$2.11 Billion | ▲ +2.6% |
| 2019 | 0.33x | NT$502.62 Million | NT$1.51 Billion | ▲ +1160.8% |
| 2018 | 0.03x | NT$33.91 Million | NT$1.29 Billion | ▼ -44.8% |
| 2017 | 0.05x | NT$62.76 Million | NT$1.31 Billion | — |